Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Buying $1000 In NVAX: If an investor had bought $1000 of NVAX stock 5 years ago, it would be worth $2,000.00 today based on a ...

It was a busy week for the biotech sector, with a lot of important data readouts and regulatory updates. Among these, Novavax ...

Buy NVAX slightly over 12.96 target 18.31 stop loss @ 12.92 Short NVAX slightly under 18.31, target 12.96, stop loss @ 18.36 ...

On Friday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $12.38 which represents a slight increase of $0.98 or 8.60% from the prior close of $11.4. The volume of shares traded was ...

Novavax, Inc. (NVAX) announced Friday that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $11.95 which represents a slight increase of $0.08 or 0.67% from the prior close of $11.87. The stock opened at $11.86 and touched a low ...

On Thursday, the FDA cleared new versions of Pfizer's (PFE) and Moderna's (MRNA) COVID-19 vaccines that are designed to match COVID-19 strains currently circulating in the country. Updated Covid-19 ...